CVS HEALTH CORPORATION REPORTS SECOND QUARTER 2024 RESULTS AND REVISES FULL-YEAR 2024 GUIDANCE

Go back to CVS HEALTH CORPORATION REPORTS SECOND QUARTER 2024 RESULTS AND REVISES FULL-YEAR 2024 GUIDANCE
CVS Caremark Corp. (NYSE: CVS) Delayed: 101.30 --0 (-0%)
Previous Close $101.30    52 Week High $106.67 
Open $101.30    52 Week Low $69.30 
Day High $101.30    P/E 27.01 
Day Low $101.30    EPS $3.75 
Volume 5,351